Collection of implementation-related data in pragmatic clinical trials: A cross-sectional study from the NIH Pragmatic Trials Collaboratory

Reflections on a principal of research ethics: Tom Beauchamp, moral specification, and waivers of informed consent

Empirical research related to the ethics of pragmatic clinical trials: A scoping review

Disentangling informing participants from obtaining their consent

Monitoring in pragmatic trials lessons from the NIH Pragmatic Trials Collaboratory

Ethical considerations for sharing aggregate results from pragmatic clinical trials

Impact of electronic health record updates and changes on the delivery and monitoring of interventions in embedded pragmatic clinical trials

Untapped potential? Representativeness in pragmatic clinical trials

Collection of patient-reported outcome measures in rural and underserved populations

Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs

Recurring and emerging ethical issues in pragmatic clinical trials

Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity

Robust analysis of stepped wedge trials using composite likelihood models

Similarities and differences between pragmatic trials and hybrid effectiveness-implementation trials

Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations

Post-trial responsibilities in pragmatic clinical trials: Fulfilling the promise of research to drive real-world change

Factors affecting post-trial sustainment or de-implementation of study interventions: a narrative review

Collecting patient-reported outcome measures in the electronic health record: Lessons from the NIH Pragmatic Trials Collaboratory

MOTIFS Publication: Think pragmatically: investigators' obligations to patient-subjects when research is embedded in care

Potential bias and lack of generalizability in electronic health record data: reflections on health equity from the National Institutes of Health Pragmatic Trials Collaboratory

Stakeholder perspectives on data sharing from pragmatic clinical trials: Unanticipated challenges for meeting emerging requirements

Improving sandwich variance estimation for marginal Cox analysis of cluster randomized trials

Analysis of multiple-period group randomized trials: random coefficients model or repeated measures ANOVA?

A value proposition for pragmatic clinical trials

Do clinicians have a duty to participate in pragmatic clinical trials?

Ethics challenges in sharing data from pragmatic clinical trials

Designing three-level cluster randomized trials to assess treatment effect heterogeneity

Toward meeting the obligation of respect for persons in pragmatic clinical trials

Promoting ethical deployment of artificial intelligence and machine learning in healthcare

Two weights make a wrong: cluster randomized trials with variable cluster sizes and heterogeneous treatment effects

Ethical and epistemic issues in the design and conduct of pragmatic stepped-wedge cluster randomized clinical trials

Responding to signals of mental and behavioral health risk in pragmatic clinical trials: ethical obligations in a healthcare ecosystem

Leave me out: patients' characteristics and reasons for opting out of a pragmatic clinical trial involving medication adherence

Incentives and payments in pragmatic clinical trials: scientific, ethical, and policy considerations

Enhancing the use of EHR systems for pragmatic embedded research: lessons from the NIH Health Care Systems Research Collaboratory

MOTIFS Publication: Identification and management of pragmatic clinical trial collateral findings: A current understanding and directions for future research

MOTIFS Publication: Patients' reactions to letters communicating collateral findings of pragmatic clinical trials: a national web-based survey

Accounting for quality improvement during the conduct of embedded pragmatic clinical trials within healthcare systems: NIH Collaboratory case studies

Ethical and regulatory concerns in pragmatic clinical trial monitoring and oversight

MOTIFS Publication: Stakeholder perspectives regarding pragmatic clinical trial collateral findings

Diversity Supplement Publication: Sample size requirements for detecting treatment effect heterogeneity in cluster randomized trials

MOTIFS Publication: Patients' views about the disclosure of collateral findings in pragmatic clinical trials: a focus group study

Certificates of confidentiality and unexpected complications for pragmatic clinical trials

Mixed-effects models for the design and analysis of stepped wedge cluster randomized trials: an overview

Diversity Supplement Publication: Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: race as an example

MOTIFS Publication: Response to open peer commentaries on 'Ethics and collateral findings in pragmatic clinical trials'

MOTIFS Publication: Ethics and collateral findings in pragmatic clinical trials

ADAPTABLE Supplement Publication: Design and analytic considerations for using patient-reported health data in pragmatic clinical trials: report from an NIH Collaboratory roundtable

Diversity Supplement Publication: Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: a systematic review

Empirical Ethics Supplement Publication: Public views regarding the responsibility of patients, clinicians, and institutions to participate in research in the United States